Use access key #2 to skip to page content.
$2.98 0.13 (4.56%)
9/5/2008 4:00 PM

MannKind Corp (MNKD)

CAPS Rating:
**

A biopharmaceutical company focused on the development and commercialization of therapeutic products for diseases such as diabetes and cancer.

View All Commentary (MNKD)

Recs

3

Avatar pa2818185 (< 20) Submitted: 8/30/06 9:46 PM : Outperform Start Price: $17.82 MNKD Score: -78.36

Superior inahled insulin device and forumulation making this a potential leader in the inhaled insulin market. Would be surprised to see the company bought by another large Pharma once the inhaled insulin market is established.

Report this Post Replies: 1 | Reply

Avatar TMFEldrehad (99.99) Submitted: 9/19/06 8:33 PM

Recs: 0 | Rec This

The question is, at the rate this company is going through cash, will they last that long?

Report this Post Reply

Featured Broker Partners